Cellectis (Cellectis) Days Payable : 10,008.51 (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Cellectis Days Payable?

Cellectis's average Accounts Payable for the three months ended in Sep. 2023 was $19.85 Mil. Cellectis's Cost of Goods Sold for the three months ended in Sep. 2023 was $0.18 Mil. Hence, Cellectis's Days Payable for the three months ended in Sep. 2023 was 10,008.51.

The historical rank and industry rank for Cellectis's Days Payable or its related term are showing as below:

CLLS' s Days Payable Range Over the Past 10 Years
Min: 717.31 Med: 1690.38 Max: 6950.71
Current: 6198.29

During the past 13 years, Cellectis's highest Days Payable was 6950.71. The lowest was 717.31. And the median was 1690.38.

CLLS's Days Payable is ranked better than
93.57% of 715 companies
in the Biotechnology industry
Industry Median: 148.78 vs CLLS: 6198.29

Cellectis's Days Payable increased from Sep. 2022 (5,782.32) to Sep. 2023 (10,008.51). It may suggest that Cellectis delayed paying its suppliers.

Cellectis Days Payable Historical Data

The historical data trend for Cellectis's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectis Days Payable Chart

Cellectis Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

1,688.61

723.26

5,039.38

4,787.26

4,657.05

Cellectis Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															5,782.32	2,892.60	5,980.43	34,470.10	10,008.51

Competitive Comparison of Cellectis's Days Payable

For the Biotechnology subindustry, Cellectis's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellectis's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectis's Days Payable distribution charts can be found below:

* The bar in red indicates where Cellectis's Days Payable falls into.

Cellectis Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cellectis's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (23.762	+	21.456)	/	2 )	/	1.772	*	365
=	22.609					/	1.772	*	365
=	4,657.05

Cellectis's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (19.229	+	20.476)	/	2 )	/	0.181	*	365 / 4
=	19.8525					/	0.181	*	365 / 4
=	10,008.51

Cellectis Days Payable Related Terms

Thank you for viewing the detailed overview of Cellectis's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellectis (Cellectis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (NAS:CLLS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CMVLF:USA 0WA2:UK ALCLS:France ZVAA:Germany

Address

8, rue de la Croix Jarry, Paris, FRA, 75013

Website

https://www.cellectis.com

Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.